1. 1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50:e1-88. https://doi.org/10.1093/ejcts/ezw313; PMID: 27663299.
2. 2. Nyong J, Amit G, Adler AJ, et al. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. Cochrane Database Syst Rev 2016;11:CD012088. https://doi. org/10.1002/14651858.CD012088.pub2; PMID: 27871122.
3. 3. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:2071-104. https://doi.org/10.1161/ CIR.0000000000000040; PMID: 24682348.
4. 4. Darby AE. Recurrent atrial fibrillation after catheter ablation: considerations for repeat ablation and strategies to optimize success. J Atr Fibrillation 2016;9:1427. https://doi.org/ 10.4022/ jafib.1427; PMID: 27909521.
5. 5. Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 2005;45:285-92. https://doi.org/10.1016/j. jacc.2004.10.035; PMID: 15653029.